A novel model of artificial intelligence based automated image analysis of CT urography to identify bladder cancer in patients investigated for macroscopic hematuria
DOI:
https://doi.org/10.2340/sju.v59.39930Keywords:
Artificial intelligence, bladder cancer, computed tomography, convolutional neural networks, hematuriaAbstract
Objective: To evaluate whether artificial intelligence (AI) based automatic image analysis utilising convolutional neural networks (CNNs) can be used to evaluate computed tomography urography (CTU) for the presence of urinary bladder cancer (UBC) in patients with macroscopic hematuria.
Methods: Our study included patients who had undergone evaluation for macroscopic hematuria. A CNN-based AI model was trained and validated on the CTUs included in the study on a dedicated research platform (Recomia.org). Sensitivity and specificity were calculated to assess the performance of the AI model. Cystoscopy findings were used as the reference method.
Results: The training cohort comprised a total of 530 patients. Following the optimisation process, we developed the last version of our AI model. Subsequently, we utilised the model in the validation cohort which included an additional 400 patients (including 239 patients with UBC). The AI model had a sensitivity of 0.83 (95% confidence intervals [CI], 0.76–0.89), specificity of 0.76 (95% CI 0.67–0.84), and a negative predictive value (NPV) of 0.97 (95% CI 0.95–0.98). The majority of tumours in the false negative group (n = 24) were solitary (67%) and smaller than 1 cm (50%), with the majority of patients having cTaG1–2 (71%).
Conclusions: We developed and tested an AI model for automatic image analysis of CTUs to detect UBC in patients with macroscopic hematuria. This model showed promising results with a high detection rate and excessive NPV. Further developments could lead to a decreased need for invasive investigations and prioritising patients with serious tumours.
Downloads
References
IARC. C.T. Estimated number of new cases in 2020, worldwide, both sexes, all ages. 2021 [cited 1st June 2021]. Available from: https://gco.iarc.fr/today/online-analysis-table
RBosetti C, Bertuccio P, Chatenoud L, et al. Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol. 2011 Jul;60(1):1-15.
https://doi.org/10.1016/j.eururo.2011.03.047 DOI: https://doi.org/10.1016/j.eururo.2011.03.047
Trinh TW, Glazer DI, Sadow CA, et al. Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results. Abdom Radiol (NY). 2018;43(3):663–671.
https://doi.org/10.1007/s00261-017-1249-6 DOI: https://doi.org/10.1007/s00261-017-1249-6
Van Der Molen AJ, Cowan NC, Mueller-Lisse UG, et al. CT urography: definition, indications and techniques. A guideline for clinical practice. Eur Radiol. 2008;18(1):4–17.
https://doi.org/10.1007/s00330-007-0792-x DOI: https://doi.org/10.1007/s00330-007-0792-x
Helenius M, Brekkan E, Dahlman P, et al. Bladder cancer detection in patients with gross haematuria: computed tomography urography with enhancement-triggered scan versus flexible cystoscopy. Scand J Urol. 2015;49(5):377–381.
https://doi.org/10.3109/21681805.2015.1026937 DOI: https://doi.org/10.3109/21681805.2015.1026937
Abuhasanein S, Hansen C, Vojinovic D, et al. Computed tomography urography with corticomedullary phase can exclude urinary bladder cancer with high accuracy. BMC Urol. 2022;22(1):60.
https://doi.org/10.1186/s12894-022-01009-4 DOI: https://doi.org/10.1186/s12894-022-01009-4
Cha KH, Hadjiiski L, Samala RK, et al. Urinary bladder segmentation in CT urography using deep-learning convolutional neural network and level sets. Med Phys. 2016;43(4):1882.
https://doi.org/10.1118/1.4944498 DOI: https://doi.org/10.1118/1.4944498
Drouin SJ, Yates DR, Hupertan V, et al. A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting. World J Urol. 2013;31(1):109–116.
https://doi.org/10.1007/s00345-012-1008-9 DOI: https://doi.org/10.1007/s00345-012-1008-9
Suarez-Ibarrola R, Hein S, Reis G, et al. Current and future applications of machine and deep learning in urology: a review of the literature on urolithiasis, renal cell carcinoma, and bladder and prostate cancer. World J Urol. 2020;38(10):2329–2347.
https://doi.org/10.1007/s00345-019-03000-5 DOI: https://doi.org/10.1007/s00345-019-03000-5
Borhani S, Borhani R, Kajdacsy-Balla A. Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction. Crit Rev Oncol Hematol. 2022;171:103601.
https://doi.org/10.1016/j.critrevonc.2022.103601 DOI: https://doi.org/10.1016/j.critrevonc.2022.103601
Mongan J, Moy L, Kahn, CE Jr. Checklist for artificial intelligence in medical imaging (CLAIM): a guide for authors and reviewers. Radiol Artif Intell. 2020;2(2):e200029.
https://doi.org/10.1148/ryai.2020200029 DOI: https://doi.org/10.1148/ryai.2020200029
Brierley J, Gospodarowicz M, Wittekind C. TNM classification of malignant tumours. 8th ed. John Wiley and Sons, Hoboken, New Jersey, USA; 2017. DOI: https://doi.org/10.1002/9780471420194.tnmc26.pub3
Busch C, Algaba, F. The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems. Virchows Arch. 2002;441(2):105–108.
https://doi.org/10.1007/s00428-002-0633-x DOI: https://doi.org/10.1007/s00428-002-0633-x
Trägårdh E, Borrelli P, Kaboteh R, et al. RECOMIA-a cloud-based platform for artificial intelligence research in nuclear medicine and radiology. EJNMMI Phys. 2020;7(1):51.
https://doi.org/10.1186/s40658-020-00316-9 DOI: https://doi.org/10.1186/s40658-020-00316-9
Çiçek, Ö, Abdulkadir A, Lienkamp S, et al. 3D U-Net: Learning dense volumetric segmentation from sparse annotation. In medical image computing and computer-assisted intervention – MICCAI 2016. Cham: Springer International Publishing; 2016. DOI: https://doi.org/10.1007/978-3-319-46723-8_49
Edenbrandt L, Enqvist O, Larsson M, Ulén J. Organ Finder – a new AI-based organ segmentation tool for CT. MedRxiv. New York, United States; 2022. DOI: https://doi.org/10.1101/2022.11.15.22282357
Gordon MN, Hadjiiski LM, Cha KH, et al. Deep-learning convolutional neural network: Inner and outer bladder wall segmentation in CT urography. Med Phys. 2019;46(2): 634–648.
https://doi.org/10.1002/mp.13326 DOI: https://doi.org/10.1002/mp.13326
Liu X, Faes L, Kale AU, et al. A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: A systematic review and meta-analysis. The Lancet Digit Health. 2019;1(6): e271–e297.
https://doi.org/10.1016/S2589-7500(19)30123-2 DOI: https://doi.org/10.1016/S2589-7500(19)30123-2
Ikeda A, Nosato H, Kochi Y, et al. Support system of cystoscopic diagnosis for bladder cancer based on artificial intelligence. J Endourol. 2020;34(3):352–358.
https://doi.org/10.1089/end.2019.0509 DOI: https://doi.org/10.1089/end.2019.0509
Lorencin I, Anđelić N, Španjol J, Car Z. Using multi-layer perceptron with Laplacian edge detector for bladder cancer diagnosis. Artif Intell Med. 2020;102:101746.
https://doi.org/10.1016/j.artmed.2019.101746 DOI: https://doi.org/10.1016/j.artmed.2019.101746
Eminaga O, Eminaga N, Semjonow A, Breil B. Diagnostic classification of cystoscopic images using deep convolutional neural networks. JCO Clin Cancer Inform. 2018;2:1–8.
https://doi.org/10.1200/CCI.17.00126 DOI: https://doi.org/10.1200/CCI.17.00126
Cha KH, Hadjiiski LM, Cohan RH, et al. Diagnostic accuracy of CT for prediction of bladder cancer treatment response with and without computerized decision support. Acad Radiol. 2019;26(9):1137–1145.
https://doi.org/10.1016/j.acra.2018.10.010 DOI: https://doi.org/10.1016/j.acra.2018.10.010
Garapati SS, Hadjiiski L, Cha KH, et al. Urinary bladder cancer staging in CT urography using machine learning. Med Phys. 2017;44(11):5814–5823.
https://doi.org/10.1002/mp.12510 DOI: https://doi.org/10.1002/mp.12510
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Suleiman Abuhasanein, Lars Edenbrandt, Olof Enqvist, Staffan Jahnson, Henrik Leonhardt, Elin Trägårdh, Johannes Ulén, Henrik Kjölhede
This work is licensed under a Creative Commons Attribution 4.0 International License.
Acta Chirurgica Scandinavica Society owns the copyright for all material published until Volume 57 (2023) unless otherwise specified. As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.